In Editing RNA, Researchers See Endless Possibilities

RNA editing has been in DNA editing’s shadow for nearly a decade, but recent investments in the technology could bring it into the limelight.

Written byChristie Wilcox, PhD
| 12 min read
Metal and colorful model of RNA
Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

Rett syndrome seems to appear out of nowhere. Infants with the rare neurological disorder grow and develop normally at first, but then—generally between 6 and 18 months of age—they suddenly regress. Toddlers forget their words, lose the ability to crawl or walk, develop involuntary hand movements and sometimes seizures, and can even struggle to eat or breathe. The children, predominantly girls, “are very sick,” explains Gail Mandel, a molecular neurobiologist at Oregon Health & Science University who has studied the condition for more than a decade.

The symptoms stem from loss-of-function mutations in a gene near the tip of the X chromosome that codes for methyl CpG binding protein 2 (MeCP2). This protein is a transcription factor, and it’s especially abundant in the central nervous system, where it helps to ensure that particular genes are switched off at the right time during development. “We know a lot about how this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

December 2021 Cover
December 2021

Return of the worms

Researchers are carefully considering the therapeutic potential of helminths

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas